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by Ho-il Kang,' Chieko Konishi,' Toshio Kuroki, 'and
Nam-ho Huh'
Formation andaccumulationofO-alkylguanine and 04-alkylthymine inhuman tissues is possibly the most relevant
markerforcancerrisk. BecausehumansarechronicallyexposedtodiversekindsofchemicalsandeventualDNAstruc-
turalmodificationsaresupposedtobeacomplexmixtureofadductsatverylowlevels, itisessential touseanassaywith
extremely highsensitivity andspecificity. V& haveestablishedaquantitationmethod,calledPREPI, forO'-nethylguanine,
04-methylthymine, and 04-ethylthymine by the combination ofprefractionation by HPLC, 32P-postlabeling, and im-
munoprecipitation. Thedetectionlimitwasabout 1 fmoleforanlthreeadducts,enablingustoanlyzeabout 1 x 10-8levels
asamolarratiotonormalcounterpart using 100ugofDNA. Inapilotexperiment, weanalyzed 11periphenl bloodsamples
fromhealthy volunteers. O-Methylguanine wasdetected inall thecases withamean valueof2.0 ± 1.3 x 10-8 (range,
078-4.6 x 10-8). Neither O-methylthymine nor 04-ethylthymine wasabovethedetection limitof08 x 10-' asa ratioto
thymine.
Introduction
06-Alkylguanine and 04-allkylthymine have been dem-
onstrated tobethe most relevantlesions among DNAmodifica-
tions forinductionofcancerbyN-nitrosocompounds indiverse
experimental systems (1-3). Detection ofsuch DNA lesions in
human tissues, therefore, is one of the best markers for the
biologically relevant exposure toalkylating agentsand may even-
tuallly lead to a better risk assessment (4-6). Because DNA
modifications in human tissues have been previously dem-
onstrated to be atextremely low levels, the use ofan assay with
high sensitivity as well as specificity is needed for molecular
epidemiological studies on cancer in man. To address this pro-
blem, we have established a quantitation method for 0-alkyl
DNA adducts andexamined itsvalidity forapplicationtohuman
samples in apilot experiment.
Materials and Methods
DNA wasenzymatically hydrolyzed tonucleoside-3 '-mono-
phosphate (3'-MP) using microccocal nuclease and spleen
phosphodiesterase (7). Eachalkylated 3 '-MP wasfractionated
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by areverse-phase HPLCsystemunderessentiallythesamecon-
ditions as previously described (5). The alkylated 3'-MP was
thenphosphorylatedby polynucleotide kinaseand [32P]ATPac-
cording toReddyetal. (7), followedby 3'-dephosphorylationby
decreasingthepH to6.0(8) forbetterrecognitionbyantibodies.
After purification by HPLC, alkylated 5'-[32-P]MP was im-
munoprecipitated with corresponding monoclonal antibodies
[ER-6for06-methylguanine, EM-3-33 for04-methylthymine,
andER-01 for04-ethylthymine (9,10)], andtheradioactivity was
determined by liquid scintillation counting. Human DNA
samples wereisolatedfromperipheral leukocytesof 11 healthy
volunteerswhohadnoapparenthistoryofexposuretoalkylating
agents.
Results and Discussion
Procedure ofPREPI
Conditions ofeach reaction step were optimized using stan-
dard DNA treated withN-methyl-N-nitrosourea orN-ethyl-N-
nitrosourea. The content of 06-methylguanine (06-MetG),
04-methylthymine (04-MetT), and 04-ethylthymine (04-EtT) in
the standard DNA was determined by competitive radioim-
munoassayusingtritiatedtracersandantibodiesasdescribed(5).
CompletionofDNAhydrolysis wasmonitoredbyinjecting ali-
quots onto HPLC. 06-Methylguanosine-3 '-monophosphate,
04-methylthymidine-3'-monophosphate, 06-ethylguanosine-
3'-monophosphate, and 04-ethylthymidine-3'-monophosphate270 KANGETAL.
couldbeseparated fromeachotherandalsofromnormal3'-MP
under the present conditions, which facilitated independent
analysis ofeachadduct fromagivenamountofDNAandreduc-
ed the amount of [32P]ATP necessary in comparison with the
original postlabeling method. Afterpostlabeling, 3'-phosphate
was removedtoenhance the recognition by antibodies because
the monoclonal antibodies used wereoriginally raised against
alkylatednucleosides (9,10). ThesecondHPLCfractionatedwas
usedto remove [32P]ATPandnonspecificradioactivebyproducts
before final immunoprecipitation. The precise amount of
alkylated DNA adducts was determined by comparing a curve
obtained by serial dilution ofsamples with a standard curve.
Sensitivity ofthe Method
A representative standard curvefor04-EtTisshowninFigure
1. Standard curves for 06-MetG and 04-MetT wereessentially
similar to that for 04-EtT (data not shown). One femtomole of
each alkylationproductcouldbeprecisely determined. There-
fore, the relative sensitivity (11), i.e., the lowest relative
modification level tobedetermined isabout 1 x 10-8asamolar
ratiotonormalcounterpartwhen 100ygofDNAisavailablefor
analysis (Table 1).
Specificity
Combining several analytical methodswithdifferentphysico-
chemical bases is preferable for attaining the high specificity
needed, particularly inthecaseofhumansamples. Thepresent
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FIGURE 1. A representative standard curve for 04-ethylthymine. Abscissa
showstheamountof04-ethylthymine determinedbyradioimmunoassay. Or-
dinate isradioactivity oftheimmunoprecipitates atthefinal stepofPREPI.
TIble 1. Comparison ofdetection methods for O-ethyltlymine.
Absolute sen- Relative
Method sitivity, fmole DNAgg sensitivity Specificity
ISB 2 25 1.5 x 10-7 Moderate
HPLC + RIA 300 20 1.5 x 10-8 High
PREPI I 1 x 10-9 Veryhigh
100 1 x10-8
Abbreviations: ISB, immuno-slot-blot; HPLC, high-pressure liquid
chromatography; RIA, radioimmunoassay; PREPI, prefractionationby HPLC,
32P-postlabeling, and immumoprecipitation.
method ishighly specificbecause each step, i.e., reverse-phase
HPLC fractionation, enzymatic reactions including postlabel-
ing, and immunoprecipitation, contribute to increasing the
specificity through different physicochemical or molecular
mechanisms.
Relevanceversus Feasibility
The validity ofany analytical methods for use in molecular
epidemiological studieswithrespecttocancermaybeassessed
bytwoindependentparameters: relevancetocancerdevelopment
andfeasibility oreaseofuseformassscreening. Quantitationof
O-alkylatedDNAadductsisconsideredtohavehigherrelevance
tocarcinogenesis thanhemoglobinadductsorN7-alkylguanine,
forexample. Inourprevious studies, todetect04-EtT inhuman
liverDNAbyradioimmunoassay usingatritiatedtracer, wehad
tousemorethan20mgofDNA(correspondingto20-30gliver
tissue) because ofthe limited sensitivity. We attempted to im-
provethefeasibilityby increasingthesensitivity ofthequantita-
tion method without sacrifying the relevance. In the present
assay, we need only 100 ytg DNA (corresponding to 10 mL of
peripheral bloodorseveral hundredmilligrams ofbiopsytissue
specimens) for the analysis of similar relative modification
levels.
AnalysisofHuman Leukocyte DNA
Toexaminethevalidity ofthepresentmethod, wequantitated
06-MetG, 04-MetT, and 04-EtT inperipheral leukocyte DNA
obtained from 11 healthy volunteers. 06-MetG was detected in
all 11 cases, with a mean value of2.0 ± 1.3 x 10 8 (range
0.78-4.6 x 10 8) as amolarratiotoguanine. 04-MetTand O4--
EtT were below the detection limit of0.8 x 10 8 as a ratio to
thymine. The result indicates that humans are exogenously
and/orendogenouslyexposedtomethylating agents, andthepre-
sentmethodcanbepracticallyappliedtotheanalysisofhuman
samples. Wearenowundertaking studiesonapossiblecorrela-
tionbetweenlevelsofalkylated DNAadductsandtheincidence
ofcancer using the method described above.
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